Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption.

Billings H, Wines BD, Dyer WB, Center RJ, Trist HM, Kent SJ, Hogarth PM.

AIDS Res Hum Retroviruses. 2019 Aug 21. doi: 10.1089/AID.2019.0047. [Epub ahead of print]

PMID:
31288562
2.

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1.

Lewis GK, Ackerman ME, Scarlatti G, Moog C, Robert-Guroff M, Kent SJ, Overbaugh J, Reeves RK, Ferrari G, Thyagarajan B.

Front Immunol. 2019 May 10;10:1025. doi: 10.3389/fimmu.2019.01025. eCollection 2019. Review.

3.

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.

Bangaru S, Lang S, Schotsaert M, Vanderven HA, Zhu X, Kose N, Bombardi R, Finn JA, Kent SJ, Gilchuk P, Gilchuk I, Turner HL, García-Sastre A, Li S, Ward AB, Wilson IA, Crowe JE Jr.

Cell. 2019 May 16;177(5):1136-1152.e18. doi: 10.1016/j.cell.2019.04.011.

PMID:
31100268
4.

Moving the HIV vaccine field forward: concepts of protective immunity.

Kent SJ, Davenport MP.

Lancet HIV. 2019 Jun;6(6):e406-e410. doi: 10.1016/S2352-3018(19)30134-1. Epub 2019 May 9.

PMID:
31080107
5.

Short Communication: Effect of Seminal Plasma on Functions of Monocytes and Granulocytes.

Selva KJ, Juno JA, Worley MJ, Chung AW, Tachedjian G, Kent SJ, Parsons MS.

AIDS Res Hum Retroviruses. 2019 Jun;35(6):553-556. doi: 10.1089/AID.2018.0219.

PMID:
31037950
6.

Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles.

Weiss ACG, Kelly HG, Faria M, Besford QA, Wheatley AK, Ang CS, Crampin EJ, Caruso F, Kent SJ.

ACS Nano. 2019 May 28;13(5):4980-4991. doi: 10.1021/acsnano.9b00552. Epub 2019 Apr 18.

PMID:
30998312
7.

Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice.

Tan HX, Esterbauer R, Vanderven HA, Juno JA, Kent SJ, Wheatley AK.

Front Immunol. 2019 Mar 29;10:611. doi: 10.3389/fimmu.2019.00611. eCollection 2019.

8.

Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques.

Khanna M, Jackson RJ, Alcantara S, Amarasena TH, Li Z, Kelleher AD, Kent SJ, Ranasinghe C.

Sci Rep. 2019 Apr 5;9(1):5661. doi: 10.1038/s41598-019-41506-5.

9.

Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.

Cui J, Ju Y, Houston ZH, Glass JJ, Fletcher NL, Alcantara S, Dai Q, Howard CB, Mahler SM, Wheatley AK, De Rose R, Brannon PT, Paterson BM, Donnelly PS, Thurecht KJ, Caruso F, Kent SJ.

Adv Healthc Mater. 2019 May;8(9):e1801607. doi: 10.1002/adhm.201801607. Epub 2019 Mar 14.

PMID:
30868751
10.

Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models.

Juno JA, Wragg KM, Kristensen AB, Lee WS, Selva KJ, van der Sluis RM, Kelleher AD, Bavinton BR, Grulich AE, Lewin SR, Kent SJ, Parsons MS.

J Virol. 2019 May 15;93(11). pii: e00242-19. doi: 10.1128/JVI.00242-19. Print 2019 Jun 1.

PMID:
30867307
11.

CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Lee WS, Prévost J, Richard J, van der Sluis RM, Lewin SR, Pazgier M, Finzi A, Parsons MS, Kent SJ.

J Virol. 2019 May 1;93(10). pii: e01901-18. doi: 10.1128/JVI.01901-18. Print 2019 May 15.

PMID:
30842324
12.

Identification of murine antigen-specific T follicular helper cells using an activation-induced marker assay.

Jiang W, Wragg KM, Tan HX, Kelly HG, Wheatley AK, Kent SJ, Juno JA.

J Immunol Methods. 2019 Apr;467:48-57. doi: 10.1016/j.jim.2019.02.008. Epub 2019 Feb 22.

PMID:
30802449
13.

MAIT Cells Upregulate α4β7 in Response to Acute Simian Immunodeficiency Virus/Simian HIV Infection but Are Resistant to Peripheral Depletion in Pigtail Macaques.

Juno JA, Wragg KM, Amarasena T, Meehan BS, Mak JYW, Liu L, Fairlie DP, McCluskey J, Eckle SBG, Kent SJ.

J Immunol. 2019 Apr 1;202(7):2105-2120. doi: 10.4049/jimmunol.1801405. Epub 2019 Feb 18.

PMID:
30777923
14.

Role of IgG3 in Infectious Diseases.

Damelang T, Rogerson SJ, Kent SJ, Chung AW.

Trends Immunol. 2019 Mar;40(3):197-211. doi: 10.1016/j.it.2019.01.005. Epub 2019 Feb 10. Review.

PMID:
30745265
15.

Immunological basis for enhanced immunity of nanoparticle vaccines.

Kelly HG, Kent SJ, Wheatley AK.

Expert Rev Vaccines. 2019 Mar;18(3):269-280. doi: 10.1080/14760584.2019.1578216. Epub 2019 Feb 14. Review.

PMID:
30707635
16.

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin.

Liu Y, Tan HX, Koutsakos M, Jegaskanda S, Esterbauer R, Tilmanis D, Aban M, Kedzierska K, Hurt AC, Kent SJ, Wheatley AK.

Nat Commun. 2019 Jan 18;10(1):324. doi: 10.1038/s41467-018-08165-y.

17.

Perturbation of mucosal-associated invariant T cells and iNKT cells in HIV infection.

Juno JA, Phetsouphanh C, Klenerman P, Kent SJ.

Curr Opin HIV AIDS. 2019 Mar;14(2):77-84. doi: 10.1097/COH.0000000000000526.

PMID:
30585802
18.

Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways.

Jegaskanda S, Vanderven HA, Tan HX, Alcantara S, Wragg KM, Parsons MS, Chung AW, Juno JA, Kent SJ.

J Virol. 2019 Feb 19;93(5). pii: e02090-18. doi: 10.1128/JVI.02090-18. Print 2019 Mar 1.

19.

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem.

Tan HX, Jegaskanda S, Juno JA, Esterbauer R, Wong J, Kelly HG, Liu Y, Tilmanis D, Hurt AC, Yewdell JW, Kent SJ, Wheatley AK.

J Clin Invest. 2019 Feb 1;129(2):850-862. doi: 10.1172/JCI123366. Epub 2019 Jan 22.

20.

Rural and urban differences in orthognathic surgical patients in the north east of Scotland.

Kent SJW, Morrison R.

Br J Oral Maxillofac Surg. 2018 Dec;56(10):931-935. doi: 10.1016/j.bjoms.2018.10.271. Epub 2018 Oct 25.

PMID:
30482600
21.

Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.

Parsons MS, Lee WS, Kristensen AB, Amarasena T, Khoury G, Wheatley AK, Reynaldi A, Wines BD, Hogarth PM, Davenport MP, Kent SJ.

J Clin Invest. 2019 Jan 2;129(1):182-191. doi: 10.1172/JCI122466. Epub 2018 Nov 26.

22.

Ageing in patients with chronic HIV infection: impact of hypercoagulation.

Kent SJ, Flexner C.

AIDS Res Ther. 2018 Nov 24;15(1):22. doi: 10.1186/s12981-018-0211-1. Review.

23.

Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.

Anand SP, Prévost J, Baril S, Richard J, Medjahed H, Chapleau JP, Tolbert WD, Kirk S, Smith AB 3rd, Wines BD, Kent SJ, Hogarth PM, Parsons MS, Pazgier M, Finzi A.

J Virol. 2019 Jan 17;93(3). pii: e01823-18. doi: 10.1128/JVI.01823-18. Print 2019 Feb 1.

24.

Functional cure of HIV: the scale of the challenge.

Davenport MP, Khoury DS, Cromer D, Lewin SR, Kelleher AD, Kent SJ.

Nat Rev Immunol. 2019 Jan;19(1):45-54. doi: 10.1038/s41577-018-0085-4.

PMID:
30410126
25.

Minimum information reporting in bio-nano experimental literature.

Faria M, Björnmalm M, Thurecht KJ, Kent SJ, Parton RG, Kavallaris M, Johnston APR, Gooding JJ, Corrie SR, Boyd BJ, Thordarson P, Whittaker AK, Stevens MM, Prestidge CA, Porter CJH, Parak WJ, Davis TP, Crampin EJ, Caruso F.

Nat Nanotechnol. 2018 Sep;13(9):777-785. doi: 10.1038/s41565-018-0246-4. Epub 2018 Sep 6. Review.

26.

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1.

Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM.

Front Immunol. 2018 Aug 20;9:1809. doi: 10.3389/fimmu.2018.01809. eCollection 2018.

27.

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies.

Parsons MS, Chung AW, Kent SJ.

Retrovirology. 2018 Aug 22;15(1):58. doi: 10.1186/s12977-018-0438-x. Review.

28.

The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIV.

Lopez E, Shattock RJ, Kent SJ, Chung AW.

AIDS Res Hum Retroviruses. 2018 Sep;34(9):727-738. doi: 10.1089/AID.2018.0099. Epub 2018 Aug 27.

PMID:
30056749
29.

Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine.

Cheeseman HM, Day S, McFarlane LR, Fleck S, Miller A, Cole T, Sousa-Santos N, Cope A, Cizmeci D, Tolazzi M, Hwekwete E, Hannaman D, Kratochvil S, McKay PF, Chung AW, Kent SJ, Cook A, Scarlatti G, Abraham S, Combadiere B, McCormack S, Lewis DJ, Shattock RJ.

Hum Gene Ther. 2018 Sep;29(9):1011-1028. doi: 10.1089/hum.2018.075.

30.

A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA.

Bangaru S, Zhang H, Gilchuk IM, Voss TG, Irving RP, Gilchuk P, Matta P, Zhu X, Lang S, Nieusma T, Richt JA, Albrecht RA, Vanderven HA, Bombardi R, Kent SJ, Ward AB, Wilson IA, Crowe JE Jr.

Nat Commun. 2018 Jul 10;9(1):2669. doi: 10.1038/s41467-018-04704-9.

31.

Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection.

Parsons MS, Le Grand R, Kent SJ.

Viruses. 2018 Jun 18;10(6). pii: E333. doi: 10.3390/v10060333. Review.

32.

Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.

Juno JA, Waruk JLM, Wragg KM, Mesa C, Lopez C, Bueti J, Kent SJ, Ball TB, Kiazyk SA.

Front Immunol. 2018 May 17;9:1076. doi: 10.3389/fimmu.2018.01076. eCollection 2018.

33.

Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Vanderven HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, Jegaskanda S, Wheatley AK, Wentworth D, Wines BD, Hogarth PM, Rockman S, Kent SJ; INSIGHT FLU005 Pilot Study Writing Group .

J Infect Dis. 2018 Sep 22;218(9):1383-1393. doi: 10.1093/infdis/jiy328.

PMID:
29860297
34.

A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge.

Carroll TD, Jegaskanda S, Matzinger SR, Fritts L, McChesney MB, Kent SJ, Fairman J, Miller CJ.

J Infect Dis. 2018 Aug 14;218(6):856-867. doi: 10.1093/infdis/jiy238.

35.

Human plasma proteome association and cytotoxicity of nano-graphene oxide grafted with stealth polyethylene glycol and poly(2-ethyl-2-oxazoline).

Wang M, Gustafsson OJR, Siddiqui G, Javed I, Kelly HG, Blin T, Yin H, Kent SJ, Creek DJ, Kempe K, Ke PC, Davis TP.

Nanoscale. 2018 Jun 14;10(23):10863-10875. doi: 10.1039/c8nr00835c.

PMID:
29658020
36.

The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.

Rasmussen TA, McMahon JH, Chang JJ, Audsley J, Rhodes A, Tennakoon S, Dantanarayana A, Spelman T, Schmidt T, Kent SJ, Morcilla V, Palmer S, Elliott JH, Lewin SR.

Lancet HIV. 2018 May;5(5):e221-e230. doi: 10.1016/S2352-3018(18)30040-7. Epub 2018 Apr 8.

PMID:
29643011
37.

Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC.

Worley MJ, Fei K, Lopez-Denman AJ, Kelleher AD, Kent SJ, Chung AW.

J Immunol Methods. 2018 Jun;457:41-52. doi: 10.1016/j.jim.2018.03.007. Epub 2018 Mar 29.

PMID:
29605231
38.

Contribution of NK Cell Education to both Direct and Anti-HIV-1 Antibody-Dependent NK Cell Functions.

Kristensen AB, Kent SJ, Parsons MS.

J Virol. 2018 May 14;92(11). pii: e02146-17. doi: 10.1128/JVI.02146-17. Print 2018 Jun 1.

39.

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.

Kratochvil S, McKay PF, Chung AW, Kent SJ, Gilmour J, Shattock RJ.

Front Immunol. 2018 Feb 27;9:342. doi: 10.3389/fimmu.2018.00342. eCollection 2018.

40.

Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.

Koutsakos M, Wheatley AK, Loh L, Clemens EB, Sant S, Nüssing S, Fox A, Chung AW, Laurie KL, Hurt AC, Rockman S, Lappas M, Loudovaris T, Mannering SI, Westall GP, Elliot M, Tangye SG, Wakim LM, Kent SJ, Nguyen THO, Kedzierska K.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaan8405. doi: 10.1126/scitranslmed.aan8405.

PMID:
29444980
41.

Identification of Native and Posttranslationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics.

Ramarathinam SH, Gras S, Alcantara S, Yeung AWS, Mifsud NA, Sonza S, Illing PT, Glaros EN, Center RJ, Thomas SR, Kent SJ, Ternette N, Purcell DFJ, Rossjohn J, Purcell AW.

Proteomics. 2018 Jun;18(12):e1700253. doi: 10.1002/pmic.201700253. Epub 2018 Apr 10.

PMID:
29437277
42.

2017 international meeting of the Global Virus Network.

Catton M, Gray G, Griffin D, Hasegawa H, Kent SJ, Mackenzie J, McSweegan E, Mercer N, Wang L.

Antiviral Res. 2018 May;153:60-69. doi: 10.1016/j.antiviral.2018.02.001. Epub 2018 Feb 5.

PMID:
29421321
43.

HIV Reactivation after Partial Protection by Neutralizing Antibodies.

Parsons MS, Cromer D, Davenport MP, Kent SJ.

Trends Immunol. 2018 May;39(5):359-366. doi: 10.1016/j.it.2017.12.006. Epub 2018 Jan 30. Review.

PMID:
29366547
44.

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.

Kratochvil S, McKay PF, Chung AW, Kent SJ, Gilmour J, Shattock RJ.

Front Immunol. 2017 Dec 20;8:1883. doi: 10.3389/fimmu.2017.01883. eCollection 2017. Erratum in: Front Immunol. 2018 Feb 27;9:342.

45.

Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?

Lee WS, Kent SJ.

Curr Opin HIV AIDS. 2018 Mar;13(2):160-166. doi: 10.1097/COH.0000000000000439. Review.

PMID:
29194123
46.

A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual Couples.

Kent SJ, Chung AW.

EBioMedicine. 2017 Dec;26:2-3. doi: 10.1016/j.ebiom.2017.11.011. Epub 2017 Nov 16. No abstract available.

47.

Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.

Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ.

J Infect Dis. 2017 Dec 27;217(1):12-23. doi: 10.1093/infdis/jix554.

PMID:
29106590
48.

Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization.

Tan HX, Wheatley AK, Esterbauer R, Jegaskanda S, Glass JJ, Masopust D, De Rose R, Kent SJ.

Mucosal Immunol. 2018 May;11(3):994-1007. doi: 10.1038/mi.2017.89. Epub 2017 Oct 25.

PMID:
29067995
49.

Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.

Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ.

Vaccine. 2017 Nov 7;35(47):6451-6458. doi: 10.1016/j.vaccine.2017.09.062. Epub 2017 Oct 10.

PMID:
29029940
50.

Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?

Cromer D, Pinkevych M, Rasmussen TA, Lewin SR, Kent SJ, Davenport MP.

J Virol. 2017 Nov 30;91(24). pii: e01395-17. doi: 10.1128/JVI.01395-17. Print 2017 Dec 15.

Supplemental Content

Support Center